Codoxime
From Wikipedia, the free encyclopedia
|
Codoxime
|
|
| Systematic (IUPAC) name | |
| (((4,5α-Epoxy-3-methoxy-17-methylmorphinan-6-ylidene)amino)oxy)acetic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H24N2O5 |
| Mol. mass | 372.415 g/mol |
| SMILES | & |
| Synonyms | Codoxime |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Codoxime is an opiate analogue that is an derivative of hydrocodone, where the 6-ketone group has been replaced by carboxymethyloxime. It has primarily antitussive effects[1] and was found to have moderate potential to cause dependence in animal studies.[2]
[edit] References
- ^ Jack Fishman. Morphinone and Codeinone Derivatives. US Patent 3153042
- ^ Jasinski DR, Martin WR. Assessment of the dependence-producing properties of dihydrocodeinone and codoxime. Clinical Pharmacology and Therapeutics. 1967 Mar-Apr;8(2):266-70. PMID 6021586

